To hear about similar clinical trials, please enter your email below

Trial Title: Percutaneous Nephroscopic Treatment of Parapelvic Cysts

NCT ID: NCT05504512

Condition: Kidney Stone
Parapelvic Cyst
Kidney Diseases
Recurrence

Conditions: Official terms:
Cysts
Kidney Diseases
Kidney Calculi
Recurrence

Conditions: Keywords:
Parapelvic Cyst
Recurrence
Kidney Diseases

Study type: Observational

Overall status: Unknown status

Study design:

Time perspective: Retrospective

Intervention:

Intervention type: Other
Intervention name: No intervention
Description: No intervention
Arm group label: Parapelvic cyst

Summary: Background of the project: The surgical treatment of parapelvic cysts is currently less researched and there is no gold standard for surgery. Previously, in percutaneous nephrolithotomy, we found that fenestration and fenestration drainage in the simultaneous treatment of pararenal pelvis cysts under nephroscopic nephroscopic surgery has clear curative effect, less trauma, and quicker recovery. Objective: To clarify the safety, efficacy and long-term efficacy of percutaneous nephroscopy in the treatment of parapelvic cysts. Nature: Retrospective case cohort study. Basic research process: Retrospective collection of cases in our hospital who underwent percutaneous nephroscopy for the treatment of parapelvic cysts, and comparison of preoperative and postoperative cyst size changes and long-term efficacy.

Criteria for eligibility:

Study pop:
Patients who have undergone percutaneous nephroscopic surgery for parapelvic cysts

Sampling method: Non-Probability Sample
Criteria:
Inclusion Criteria: - Age 18 or older - Has undergone percutaneous nephroscopic surgery for parapelvic cysts - Ability to receive study follow-up Exclusion Criteria: - Patient refuses or is unable to give consent

Gender: All

Minimum age: 18 Years

Maximum age: 70 Years

Healthy volunteers: No

Locations:

Facility:
Name: Xiangya hospital of central south university

Address:
City: Changsha
Country: China

Contact:
Last name: Hequn Chen, Ph.D

Phone: 13908475808
Email: chenhequnxy@126.com

Investigator:
Last name: Hequn Chen, Ph.D
Email: Principal Investigator

Start date: November 30, 2022

Completion date: December 31, 2023

Lead sponsor:
Agency: Xiangya Hospital of Central South University
Agency class: Other

Source: Xiangya Hospital of Central South University

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05504512

Login to your account

Did you forget your password?